0001104659-22-042261.txt : 20220404
0001104659-22-042261.hdr.sgml : 20220404
20220404163910
ACCESSION NUMBER: 0001104659-22-042261
CONFORMED SUBMISSION TYPE: 3/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211116
FILED AS OF DATE: 20220404
DATE AS OF CHANGE: 20220404
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Maraoui Claude
CENTRAL INDEX KEY: 0001893880
FILING VALUES:
FORM TYPE: 3/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41063
FILM NUMBER: 22802953
MAIL ADDRESS:
STREET 1: C/O JOURNEY MEDICAL CORPORATION
STREET 2: 9237 E VIA DE VENTURA BLVD., SUITE 105
CITY: SCOTTSDALE
STATE: AZ
ZIP: 85258
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Journey Medical Corp
CENTRAL INDEX KEY: 0001867066
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 471879539
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9237 E VIA DE VENTURA BLVD., SUITE 105
CITY: SCOTTSDALE
STATE: AZ
ZIP: 85258
BUSINESS PHONE: 480-434-6670
MAIL ADDRESS:
STREET 1: 9237 E VIA DE VENTURA BLVD., SUITE 105
CITY: SCOTTSDALE
STATE: AZ
ZIP: 85258
3/A
1
tm2211324-1_3aseq1.xml
OWNERSHIP DOCUMENT
X0206
3/A
2021-11-16
2021-11-26
0
0001867066
Journey Medical Corp
DERM
0001893880
Maraoui Claude
C/O JOURNEY MEDICAL CORPORATION,
9237 E VIA DE VENTURA BLVD., SUITE 105
SCOTTSDALE
AZ
85258
1
1
0
0
President & CEO
COMMON STOCK
1892530
D
This Form 3 amendment is being filed to correct the original Form 3 originally filed on November 26, 2021, which (i) incorrectly stated the number of restricted stock units granted to Mr. Maraoui and total number of shares of Journey Medical Corporation's common stock owned by Mr. Maraoui and (ii) omitted the vesting schedule of his restricted stock units discussed below.
Includes 442,530 unvested Restricted Stock Units granted to Mr. Maraoui, which will vest in accordance with the following schedule: 147,362 shares on the fifteenth day of the eighteenth month following the closing of our initial public offering (the "Tranche 1 Vesting Date"); 147,362 of which will vest nine months after the Tranche 1 Vesting Date (the "Tranche 2 Vesting Date"), and 147,806 of which will vest nine months after the Tranche 2 Vesting Date.
/s/ Claude Maraoui
2022-04-04